openPR Logo
Press release

Butorphanol Market 2020- Analysis And In-Depth Research On Market Size, Trends, Emerging Growth Factors And Forecast To 2026

04-09-2020 11:23 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: QY Research

Butorphanol Market 2020- Analysis And In-Depth Research

Complete study of the global Butorphanol market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of the present as well as future scenario of the global Butorphanol industry. Research techniques like PESTLE and Porter's Five Forces analysis have been deployed by the researchers. They have also provided accurate data on Butorphanol production, capacity, price, cost, margin, and revenue to help the players gain a clear understanding into the overall existing and future market situation.

Key companies operating in the global Butorphanol market include _ Hikma Pharmaceuticals, Athanas Enterprise Private Limited, Pfizer, Apothecon Pharmaceuticals, Mylan, Novex Pharma, Bristol Myers Squibb, Sanochemia Pharmazeutika, Selectavet, Richter Pharma Ag, Troy Laboratories Nz, Animedica, Boehringer Ingelheim Sant? Animale, Ausrichter, Zoetis, Dechra Pharmaceuticals, Faunapharma, Merck KGaA

Get PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) :

https://www.qyresearch.com/sample-form/form/1643040/global-butorphanol-market

Segmental Analysis

The report has classified the global Butorphanol industry into segments including product type and application. Every segment is evaluated based on growth rate and share. Besides, the analysts have studied the potential regions that may prove rewarding for the Butorphanol manufcaturers in the coming years. The regional analysis includes reliable predictions on value and volume, thereby helping market players to gain deep insights into the overall Butorphanol industry.

Global Butorphanol Market Segment By Type:

Spray, Injection, Tablet

Global Butorphanol Market Segment By Application:

Human, Veterinary

Competitive Landscape

It is important for every market participant to be familiar with the competitive scenario in the global Butorphanol industry. In order to fulfil the requirements, the industry analysts have evaluated the strategic activities of the competitors to help the key players strengthen their foothold in the market and increase their competitiveness.

Key companies operating in the global Butorphanol market include _ Hikma Pharmaceuticals, Athanas Enterprise Private Limited, Pfizer, Apothecon Pharmaceuticals, Mylan, Novex Pharma, Bristol Myers Squibb, Sanochemia Pharmazeutika, Selectavet, Richter Pharma Ag, Troy Laboratories Nz, Animedica, Boehringer Ingelheim Sant? Animale, Ausrichter, Zoetis, Dechra Pharmaceuticals, Faunapharma, Merck KGaA

Key questions answered in the report:

What is the growth potential of the Butorphanol market?
Which product segment will grab a lion's share?
Which regional market will emerge as a frontrunner in coming years?
Which application segment will grow at a robust rate?
What are the growth opportunities that may emerge in Butorphanol industry in the years to come?
What are the key challenges that the global Butorphanol market may face in future?
Which are the leading companies in the global Butorphanol market?
Which are the key trends positively impacting the market growth?
Which are the growth strategies considered by the players to sustain hold in the global Butorphanol market?
Enquire Customization in The Report: https://www.qyresearch.com/customize-request/form/1643040/global-butorphanol-market

TOC

1 Butorphanol Market Overview
1.1 Product Overview and Scope of Butorphanol
1.2 Butorphanol Segment by Type
1.2.1 Global Butorphanol Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Spray
1.2.3 Injection
1.2.4 Tablet
1.3 Butorphanol Segment by Application
1.3.1 Butorphanol Sales Comparison by Application: 2020 VS 2026
1.3.2 Human
1.3.3 Veterinary
1.4 Global Butorphanol Market Size Estimates and Forecasts
1.4.1 Global Butorphanol Revenue 2015-2026
1.4.2 Global Butorphanol Sales 2015-2026
1.4.3 Butorphanol Market Size by Region: 2020 Versus 2026
1.5 Coronavirus Disease 2019 (Covid-19): Butorphanol Industry Impact
1.5.1 How the Covid-19 is Affecting the Butorphanol Industry
1.5.1.1 Butorphanol Business Impact Assessment - Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Butorphanol Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Butorphanol Players to Combat Covid-19 Impact 2 Global Butorphanol Market Competition by Manufacturers
2.1 Global Butorphanol Sales Market Share by Manufacturers (2015-2020)
2.2 Global Butorphanol Revenue Share by Manufacturers (2015-2020)
2.3 Global Butorphanol Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Butorphanol Manufacturing Sites, Area Served, Product Type
2.5 Butorphanol Market Competitive Situation and Trends
2.5.1 Butorphanol Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Butorphanol Players (Opinion Leaders) 3 Butorphanol Retrospective Market Scenario by Region
3.1 Global Butorphanol Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Butorphanol Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Butorphanol Market Facts & Figures by Country
3.3.1 North America Butorphanol Sales by Country
3.3.2 North America Butorphanol Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Butorphanol Market Facts & Figures by Country
3.4.1 Europe Butorphanol Sales by Country
3.4.2 Europe Butorphanol Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Butorphanol Market Facts & Figures by Region
3.5.1 Asia Pacific Butorphanol Sales by Region
3.5.2 Asia Pacific Butorphanol Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Butorphanol Market Facts & Figures by Country
3.6.1 Latin America Butorphanol Sales by Country
3.6.2 Latin America Butorphanol Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Butorphanol Market Facts & Figures by Country
3.7.1 Middle East and Africa Butorphanol Sales by Country
3.7.2 Middle East and Africa Butorphanol Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E 4 Global Butorphanol Historic Market Analysis by Type
4.1 Global Butorphanol Sales Market Share by Type (2015-2020)
4.2 Global Butorphanol Revenue Market Share by Type (2015-2020)
4.3 Global Butorphanol Price Market Share by Type (2015-2020)
4.4 Global Butorphanol Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Butorphanol Historic Market Analysis by Application
5.1 Global Butorphanol Sales Market Share by Application (2015-2020)
5.2 Global Butorphanol Revenue Market Share by Application (2015-2020)
5.3 Global Butorphanol Price by Application (2015-2020) 6 Company Profiles and Key Figures in Butorphanol Business
6.1 Hikma Pharmaceuticals
6.1.1 Corporation Information
6.1.2 Hikma Pharmaceuticals Description, Business Overview and Total Revenue
6.1.3 Hikma Pharmaceuticals Butorphanol Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Hikma Pharmaceuticals Products Offered
6.1.5 Hikma Pharmaceuticals Recent Development
6.2 Athanas Enterprise Private Limited
6.2.1 Athanas Enterprise Private Limited Corporation Information
6.2.2 Athanas Enterprise Private Limited Description, Business Overview and Total Revenue
6.2.3 Athanas Enterprise Private Limited Butorphanol Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Athanas Enterprise Private Limited Products Offered
6.2.5 Athanas Enterprise Private Limited Recent Development
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description, Business Overview and Total Revenue
6.3.3 Pfizer Butorphanol Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Pfizer Products Offered
6.3.5 Pfizer Recent Development
6.4 Apothecon Pharmaceuticals
6.4.1 Apothecon Pharmaceuticals Corporation Information
6.4.2 Apothecon Pharmaceuticals Description, Business Overview and Total Revenue
6.4.3 Apothecon Pharmaceuticals Butorphanol Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Apothecon Pharmaceuticals Products Offered
6.4.5 Apothecon Pharmaceuticals Recent Development
6.5 Mylan
6.5.1 Mylan Corporation Information
6.5.2 Mylan Description, Business Overview and Total Revenue
6.5.3 Mylan Butorphanol Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Mylan Products Offered
6.5.5 Mylan Recent Development
6.6 Novex Pharma
6.6.1 Novex Pharma Corporation Information
6.6.2 Novex Pharma Description, Business Overview and Total Revenue
6.6.3 Novex Pharma Butorphanol Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Novex Pharma Products Offered
6.6.5 Novex Pharma Recent Development
6.7 Bristol Myers Squibb
6.6.1 Bristol Myers Squibb Corporation Information
6.6.2 Bristol Myers Squibb Description, Business Overview and Total Revenue
6.6.3 Bristol Myers Squibb Butorphanol Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Bristol Myers Squibb Products Offered
6.7.5 Bristol Myers Squibb Recent Development
6.8 Sanochemia Pharmazeutika
6.8.1 Sanochemia Pharmazeutika Corporation Information
6.8.2 Sanochemia Pharmazeutika Description, Business Overview and Total Revenue
6.8.3 Sanochemia Pharmazeutika Butorphanol Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Sanochemia Pharmazeutika Products Offered
6.8.5 Sanochemia Pharmazeutika Recent Development
6.9 Selectavet
6.9.1 Selectavet Corporation Information
6.9.2 Selectavet Description, Business Overview and Total Revenue
6.9.3 Selectavet Butorphanol Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Selectavet Products Offered
6.9.5 Selectavet Recent Development
6.10 Richter Pharma Ag
6.10.1 Richter Pharma Ag Corporation Information
6.10.2 Richter Pharma Ag Description, Business Overview and Total Revenue
6.10.3 Richter Pharma Ag Butorphanol Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Richter Pharma Ag Products Offered
6.10.5 Richter Pharma Ag Recent Development
6.11 Troy Laboratories Nz
6.11.1 Troy Laboratories Nz Corporation Information
6.11.2 Troy Laboratories Nz Butorphanol Description, Business Overview and Total Revenue
6.11.3 Troy Laboratories Nz Butorphanol Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Troy Laboratories Nz Products Offered
6.11.5 Troy Laboratories Nz Recent Development
6.12 Animedica
6.12.1 Animedica Corporation Information
6.12.2 Animedica Butorphanol Description, Business Overview and Total Revenue
6.12.3 Animedica Butorphanol Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Animedica Products Offered
6.12.5 Animedica Recent Development
6.13 Boehringer Ingelheim Sant? Animale
6.13.1 Boehringer Ingelheim Sant? Animale Corporation Information
6.13.2 Boehringer Ingelheim Sant? Animale Butorphanol Description, Business Overview and Total Revenue
6.13.3 Boehringer Ingelheim Sant? Animale Butorphanol Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Boehringer Ingelheim Sant? Animale Products Offered
6.13.5 Boehringer Ingelheim Sant? Animale Recent Development
6.14 Ausrichter
6.14.1 Ausrichter Corporation Information
6.14.2 Ausrichter Butorphanol Description, Business Overview and Total Revenue
6.14.3 Ausrichter Butorphanol Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Ausrichter Products Offered
6.14.5 Ausrichter Recent Development
6.15 Zoetis
6.15.1 Zoetis Corporation Information
6.15.2 Zoetis Butorphanol Description, Business Overview and Total Revenue
6.15.3 Zoetis Butorphanol Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Zoetis Products Offered
6.15.5 Zoetis Recent Development
6.16 Dechra Pharmaceuticals
6.16.1 Dechra Pharmaceuticals Corporation Information
6.16.2 Dechra Pharmaceuticals Butorphanol Description, Business Overview and Total Revenue
6.16.3 Dechra Pharmaceuticals Butorphanol Sales, Revenue and Gross Margin (2015-2020)
6.16.4 Dechra Pharmaceuticals Products Offered
6.16.5 Dechra Pharmaceuticals Recent Development
6.17 Faunapharma
6.17.1 Faunapharma Corporation Information
6.17.2 Faunapharma Butorphanol Description, Business Overview and Total Revenue
6.17.3 Faunapharma Butorphanol Sales, Revenue and Gross Margin (2015-2020)
6.17.4 Faunapharma Products Offered
6.17.5 Faunapharma Recent Development
6.18 Merck KGaA
6.18.1 Merck KGaA Corporation Information
6.18.2 Merck KGaA Butorphanol Description, Business Overview and Total Revenue
6.18.3 Merck KGaA Butorphanol Sales, Revenue and Gross Margin (2015-2020)
6.18.4 Merck KGaA Products Offered
6.18.5 Merck KGaA Recent Development 7 Butorphanol Manufacturing Cost Analysis
7.1 Butorphanol Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Butorphanol
7.4 Butorphanol Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Butorphanol Distributors List
8.3 Butorphanol Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast
10.1 Global Butorphanol Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Butorphanol by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Butorphanol by Type (2021-2026)
10.2 Butorphanol Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Butorphanol by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Butorphanol by Application (2021-2026)
10.3 Butorphanol Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Butorphanol by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Butorphanol by Region (2021-2026)
10.4 North America Butorphanol Estimates and Projections (2021-2026)
10.5 Europe Butorphanol Estimates and Projections (2021-2026)
10.6 Asia Pacific Butorphanol Estimates and Projections (2021-2026)
10.7 Latin America Butorphanol Estimates and Projections (2021-2026)
10.8 Middle East and Africa Butorphanol Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

Contact Us:-

QY Research, INC.
17890 Castleton,
Suite 218,
Los Angeles, CA - 91748
USA: +1 626 295 2442
Email:
enquiry@qyresearch.com

Web:
http://www.qyresearch.com

About Us:-

QY Research is the most reliable source to access the market research reports that will offer you a lead that your business needs. At QY Research, our key objective is to provide a platform for various world-class market research companies across the globe to circulate their research reports. We also assist decision-makers in finding suitable business solutions. QY Research Wire has a primary aim of providing an ultimate solution based on customers' requirements.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Butorphanol Market 2020- Analysis And In-Depth Research On Market Size, Trends, Emerging Growth Factors And Forecast To 2026 here

News-ID: 2005104 • Views:

More Releases from QY Research

Steel Floor Panels Market to Reach USD 17,565 Million by 2031 Top 20 Company Globally
Steel Floor Panels Market to Reach USD 17,565 Million by 2031 Top 20 Company Glo …
Steel floor panels cover a range of products used in commercial, industrial and data-center construction: profiled steel decking for composite slabs, galvanized or coated steel raised-access panels for server rooms and offices, and engineered steel mezzanine/industrial floor panels for warehouses and manufacturing plants. They are selected for strength-to-weight ratio, speed of installation, fire performance (when specified with appropriate infill), recyclability and long service life. Product differentiation is driven by profile
Electronic Home Scales Market to Reach USD 4,138 Million by 2031 Top 15 Company Globally
Electronic Home Scales Market to Reach USD 4,138 Million by 2031 Top 15 Company …
Electronic home scales, often placed in bathrooms or kitchens, are digital devices designed to measure body weight and, in many cases, additional parameters such as body fat, water content, muscle mass, and BMI using technologies like strain gauges or bio-impedance. These devices have transcended simple weight measurement to become central to consumer health tracking, fitness routines, and increasingly integrated via Bluetooth or Wi-Fi with mobile apps and smart home ecosystems.
Disposable Medical Probe Covers Market to Reach CAGR 5,5% by 2031 Top 10 Company Globally
Disposable Medical Probe Covers Market to Reach CAGR 5,5% by 2031 Top 10 Company …
Disposable medical probe covers (commonly sold as ultrasound probe covers, transducer sheaths, endocavity kits and related disposable sheathing products) are single-use barriers placed over diagnostic and interventional probes to reduce cross-contamination and support infection-control workflows in ultrasound, transesophageal echo (TEE), endocavity and certain interventional procedures. They are manufactured in a range of formats from thin polyethylene sleeves and rolled covers for external probes to individually packaged sterile endocavity kits that
Global and U.S. Vinylcyclohexene Dioxide Market Report, Published by QY Research.
Global and U.S. Vinylcyclohexene Dioxide Market Report, Published by QY Research …
Vinylcyclohexene Dioxide (VCHD) is a low-viscosity aliphatic diepoxide used as a reactive diluent and crosslinking agent in epoxy resins, coatings, adhesives, and electrical insulation systems. With two oxirane groups attached to a cycloaliphatic backbone, it offers excellent thermal stability, chemical resistance, and dielectric strength, making it suitable for high-performance composites and electronic encapsulation. https://www.qyresearch.com/reports/4934028/vinylcyclohexene-dioxide The global market for Vinylcyclohexene Dioxide is projected at USD 86 million in 2024, growing at a

All 5 Releases


More Releases for Butorphanol

Elevating Pharmaceutical Quality with Aquigen Bio's Premium Impurity Standards f …
June 2025 - In a mission to support global pharmaceutical compliance and analytical precision, Aquigen Bio has expanded its impurity standards portfolio with high-quality, certified reference materials (CRMs) for Butylhydroxyanisole, and Butorphanol. These specialized impurity standards are crucial for accurate testing, regulatory submissions, and ensuring the safety and efficacy of drug formulations. Know more about Butorphanol :https://aquigenbio.com/product/butorphanol/ Ensuring Purity with Butylhydroxyanisole Impurity Standards Butylhydroxyanisole (BHA), widely used as an antioxidant in pharmaceutical formulations,
Human Ipscs Market is Booming Worldwide: Global Research Report by Future Innova …
The Human iPSCs Market was valued at approximately USD 8.75 billion in 2023. It is projected to expand from USD 10.51 billion in 2024 to USD 45.6 billion by 2032, with an anticipated CAGR of around 20.14% throughout the forecast period (2024-2032). The Global Human iPSCs Market Research Report provides a comprehensive analysis segmented by product type, application, end user, technology, and region. It covers key categories such as Human Embryonic
Children Emergency Cervical Collars Market In-depth Analysis and Comprehensive A …
In 2024, the Wiseguy Reports latest published research report on "Children Emergency Cervical Collars market growth is growing steadily with exponential rate and a rising adoption of strategies by top industry players, over the projected horizon 2024 to 2032". Children Emergency Cervical Collars Market share was valued at 17.7 Billion US$ in 2023. The Children Emergency Cervical Collars Market Industry is expected to grow from 18.77 Billion US$ in 2024
Covid Testing Kit Market Global Trends and Business Outlook 2024 to 2032 | Abbot …
The COVID-19 pandemic has significantly transformed various sectors globally, and the COVID-19 testing kit market is no exception. This market has seen rapid growth, driven by the urgent need for widespread and efficient testing to control the spread of the virus. The evolution of COVID-19 testing kits has been marked by technological advancements, increased production capabilities, and the integration of innovative diagnostic techniques. In 2024, the Covid Testing Kit market
Butorphanol Market Revenue, Insights, Overview, Outlook, Analysis | Valuates Rep …
Butorphanol Market Butorphanol is a morphinan-type synthetic agonist-antagonist opioid analgesic developed by Bristol-Myers. Butorphanol is available as the tartrate salt in injectable, tablet, and intranasal spray formulations. The tablet form is only used in dogs, cats and horses due to low bioavailability in humans. The global Butorphanol market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast
Butorphanol Market Size, Status and Forecast TO 2026
The Latest survey report on Global Butorphanol Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Butorphanol organizations have the dual challenge of increasing interoperability to improve clinical performance and the patient experience. Some of the companies listed in the study from complete survey list are Hikma Pharmaceuticals, Athanas Enterprise Private Limited, Pfizer, Apothecon Pharmaceuticals, Mylan, Novex Pharma, Bristol Myers